Updates and Q&A
Introductions | 1:04 |
A COVID-19 Update. | 3:14 |
Impact of COVID-19 on Patients Living with Vasculitis survey report | 7:01 |
Vasculitis Community’s Feelings on the Flu and COVID-19 Vaccine Report | 9:29 |
Is there a situation where you would advise a patient with vasculitis to not get the COVID-19 vaccine? | 15:38 |
Should I hold my methotrexate treatment if I’m also getting the COVID-19 vaccine? | 18:59 |
What about the timing between my Rituximab infusion, and when I get the vaccine? | 21;45 |
Should I still wear a mask even after I get the vaccine? | 28:53 |
Are there any concerns about the use of mRNA technology as opposed to other vaccine delivery platforms? | 33:27 |
Is there an advantage of getting one type of vaccine over another one? | 37:35 |
Have these vaccines been tested on patients with vasculitis? | 41:38 |
Should I get an antibody test for COVID-19? | 42:43 |
More Patient Questions About COVID-19
Kenneth J. Warrington, M.D.
Chair, Division of Rheumatology, Professor of Medicine, Mayo Clinic
In this webinar, Dr. Ken Warrington, answers some of the patient questions about COVID-19 that weren’t included in the live, February 27 webinar. Among the discussion highlights is Kathy’s story about catching COVID-19 as a patient with vasculitis. Dr. Warrington also provides insight into the key questions being researched about the virus, and the vaccine.